Results 241 to 250 of about 165,369 (255)

Inhibitors of Cyclin-Dependent Kinase 1/2 for Anticancer Treatment

Medicinal Chemistry, 2020
Jiajia Mou, Yanru Deng
exaly  

Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status

Expert Opinion on Investigational Drugs, 2000
L R Kelland
exaly  

The cyclin-dependent kinase inhibitor p21 is required for TGF-β1-induced podocyte apoptosis

Kidney International, 2005
Jeffrey Pippin
exaly  

A cyclin-dependent kinase family member (PHOA) is required to link developmental fate to environmental conditions in Aspergillus nidulans

EMBO Journal, 1998
Stephen Osmani
exaly  

Cyclin dependent kinase regulation

Current Opinion in Cell Biology, 1995
Emma Lees, E Lees
exaly  

Cyclin Dependent Kinase 5 (CDK5) and Neurodegeneration

Clinical Science, 1999
N Bajaj, AL S-Sarraj, PN Leigh, CCJ Miller   +3 more
openaire   +1 more source

Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways

Proceedings of the National Academy of Sciences of the United States of America, 2012
Kevan Shokat, Andrei Goga, Robert Fisher   +2 more
exaly  

Homocysteine Increases Cyclin-Dependent Kinase in Aortic Rat Tissue

Circulation, 1996
Wilhelm Mosgoeller, H Hoeger, Harald Hoeger   +2 more
exaly  

Cyclin-dependent kinase inhibitors: novel anticancer agents

Expert Opinion on Investigational Drugs, 2000
Keqiang Wu, Richard Pestell, Sridhar Mani   +2 more
exaly  

Cyclin-dependent kinase 7: at the cross-roads of transcription, DNA repair and cell cycle control?

Current Opinion in Cell Biology, 1996
Erich Nigg
exaly